Status:
COMPLETED
Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC)
Lead Sponsor:
Medical University of Vienna
Conditions:
Vulvovaginal Candidiasis
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
A prospective study to evaluate the efficacy of classic homeopathic therapy compared to maintenance itraconazole therapy with and without additional exogenous lactobacillus for treatment of recurrent ...
Detailed Description
Objective: Antimycotics effectively treat sporadic and recurrent vulvovaginal candidiasis (RVVC). Classic homeopathy (CH) is also used to treat this condition. We compared the efficacy of CH and itra...
Eligibility Criteria
Inclusion
- Patients over 18 years, premenopausal
- Negative pregnancy test
- Signed informed consent
- At least 4 Episodes of Candidiasis within the last year
- Candida detectable by culture
- Negative Hepatitis- and HIV-Serology
- No Allergy to Itraconazole
Exclusion
- Under 18 years
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT00895453
Start Date
May 1 2000
End Date
February 1 2006
Last Update
November 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Medical School
Vienna, Austria, 1090